NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/15/2023
Back to search
Official data from USPTO
QXDX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
QXDX
ST13
US500000090775545Class
1, 5, 9, 10
Filing
90775545
Registration
7139941
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
08/15/2023
Trademark type
Word
Nice classes
1, 5, 9, 10
Filing date
06/15/2021
Registration date
08/15/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/15/2023
Last transaction
08/15/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2019-02-00
First use in commerce
2019-02-00
Drawing code
4
Owner type
03
Owner location
Hercules, CA, US
Examiner
DEFORD, JEFFREY S
Law office
M60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Bio-Rad Laboratories, Inc.
Representatives
Margaret C. McHugh KILPATRICK TOWNSEND & STOCKTON LLP
Technical classification
Nice Classes
Class 1Class 5Class 9Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical reagents for scientific and medical research purposes; diagnostic reagents for clinical or medical laboratory use; Polymerase Chain Reaction (PCR) and digital Polymerase Chain Reaction (dPCR) reagents for scientific and medical research purposes; reagents for amplification and detection of nucleic acids for scientific and medical research purposes; Kits comprising chemicalsreagentsenzymesbuffer solutions for amplifying and labeling nucleic acids for scientific and research use; Reagent kits comprising biological proteinDNA primerspolymerase or buffers for scientific and medical research use; Kits comprising chemicalsreagentsenzymesbuffer solutions for amplifying and labeling nucleic acids for scientific or research use; Kits consisting primarily of reagents and magneticpolymericgel beads for scientific research use purposes
Class 5
Diagnostic preparations for medical purposes; Diagnostic preparations for medical purposesreagentsenzymesoligonucleotidesbuffer solutions for amplifyinglabelinganalyzing biopolymers and nucleic acids for diagnostic medical use and clinical use; Chemical reagents for medical or veterinary purposes; Chemicalbiochemical and biotechnological preparations for medical and veterinary purposesin particular reagentsenzymes and buffer solutions for markingamplifyingquantification and/or for the analysis of biopolymersin particular nucleic acidsin particular reagentsenzymes and buffer solutions for nucleic acid amplification; Medical diagnostic reagent kits comprised of clinical medical reagents and assays for clinical and medical use; Diagnostic test kits comprised of medical diagnostic reagents and assays for testing in the field of medical diagnostics; Kits comprising chemicalsreagentsenzymesbuffer solutions for amplifying and labeling nucleic acids for diagnostic medical use and clinical use; Chemical test kits for cell assays for medical and veterinary use; Cartridges containing medical diagnostic reagents for use in Polymerase Chain Reaction (PCR) and digital Polymerase Chain Reaction (dPCR)
Class 9
Apparatusmedical laboratory research instruments and scientific laboratory research instruments for preparationhandlingamplificationanalysis of samples containing nucleic acids; accessories in the nature of laboratory apparatussample preparation containers and kits consisting primarily of sample preparation containers and reagentsinstruction manuals sold as a unit therewithused to prepare laboratory samples for use in scientific and medical researchall in connection with the preparationhandlingamplificationanalysis of samples containing nucleic acids; scientific apparatusinstruments and equipment for scientific researchnon-medical diagnostic analysischemical analysisclinical analysis and industrial useDNA and RNA testing apparatus; scientific laboratory equipment and apparatusdigital polymerase chain reaction (dPCR) apparatuselectrophoresis apparatusgel electrophoresis apparatusthermal cyclersfor use in amplifyinglabelinganalyzing nucleic acidsparts and consumable parts therefortubesplatescartridgesholderscontainers for liquids and gels; Laboratory apparatus and instrumentsdigital Polymerase Chain Reaction (dPCR) instruments for amplifying DNA using digital Polymerase Chain Reaction (dPCR) for use in scientific research; Scientific apparatus and instrumentsdroplet generators for sample preparation of nucleic acids and droplet reader for amplifying and analyzing samples containing nucleic acids; Downloadable and recorded software for use in for operation and maintenance of scientific apparatusinstruments and equipmentoperating quantitative Polymerase Chain Reaction (PCR) instruments; Polymerase Chain Reaction (PCR) instruments for use in scientific researchlaboratory apparatus and instruments for amplifying DNA using Polymerase Chain Reaction (PCR); downloadable computer software for use in amplifyinglabelinganalyzing nucleic acids; computer hardware and downloadable and integrated software for use in gene analysis); Downloadable and recorded computer software and hardware for processing diagnostic medical testing or laboratory data; Downloadable and recorded computer software and hardware for data analysis for use in laboratories; Downloadable and recorded computer software for operation and maintenance of scientific apparatusinstruments and equipment; Clinical medical laboratory apparatus and analytical instrumentsdigital Polymerase Chain Reaction (dPCR) instruments for use in-vitro and in-vivo diagnostics
Class 10
ApparatusDNA and RNA testing apparatus for medical and veterinary diagnostic analysis and determination of medical and veterinary conditions; Medical diagnostic apparatus and instrumentsPolymerase Chain Reaction (PCR) instrument to perform amplification and analyzation of nucleic acids; Medical devices and instrumentsa digital Polymerase Chain Reaction (dPCR) platform for use in measuring and quantifying copy number of DNA for medical diagnostic purposes; Medical devices and instrumentsa digital Polymerase Chain Reaction (dPCR) platform for use in measuring and quantifying copy number of DNA for medical diagnostic purposes; Diagnostic kits consisting primarily of electronic medical instruments for medical diagnosis and analysis of body fluidstissuesbiomoleculesDNAantibodiesproteinsmolecular material or cellular material
Publications
History of USPTO decisions and trademark events.
31 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
08/15/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
07/14/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
07/13/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
06/20/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
06/20/2023
IUAF
USE AMENDMENT FILED
05/26/2023
EISU
TEAS STATEMENT OF USE RECEIVED
05/26/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
11/29/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/04/2022
PUBO
PUBLISHED FOR OPPOSITION
10/04/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/14/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/26/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/29/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/29/2022
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
07/29/2022
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
04/28/2022
GNFR
FINAL REFUSAL E-MAILED
04/28/2022
CNFR
FINAL REFUSAL WRITTEN
04/28/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/14/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/13/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/13/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/04/2021
GNRT
NON-FINAL ACTION E-MAILED
11/04/2021
CNRT
NON-FINAL ACTION WRITTEN
11/04/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/20/2021
GNRT
NON-FINAL ACTION E-MAILED
09/20/2021
CNRT
NON-FINAL ACTION WRITTEN
09/20/2021
DOCK
ASSIGNED TO EXAMINER
09/20/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/02/2021
NWAP
NEW APPLICATION ENTERED
06/18/2021
Continuous trademark protection
Get notified about every new filing that threatens QXDX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.